Arsenic exposure and tobacco consumption: Biomarkers and risk assessment

Regulatory Toxicology and Pharmacology

Volumn 64, Issue 2, 2012, Pages 225-232

  Marano, Kristin M ^a   Naufal, Ziad S ^a   Kathman, Steven J ^a   Bodnar, Joy A ^a   Borgerding, Michael F ^a   Wilson, Cody L ^a  

^a R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

Arsenic; Biomonitoring; Cigarettes; Epidemiology; NHANES; Probabilistic risk assessment; Risk assessment; Smokeless tobacco; Tobacco

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; CIGARETTE SMOKE; TOBACCO SMOKE;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; HAZARD ASSESSMENT; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKELESS TOBACCO; SMOKING; URINE LEVEL;

ADULT; AGED; ARSENIC; BIOLOGICAL MARKERS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK ASSESSMENT; SMOKING; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 84865324965     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.07.007     Document Type: Article

References (57)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 2007. Toxicological profile for arsenic. (accessed 15.05.12). http://www.atsdr.cdc.gov/toxprofiles/tp2.pdf.
2. Arias, E., 2006. United States life tables, 2003. National vital statistics reports. 54(14). National Center for Health Statistics, Hyattsville, MD.
3. Ayo-Yusuf O.A., Connolly G.N. Applying toxicological risk assessment principles to constituents of smokeless tobacco products: implications for product regulation. Tob. Control 2011, 20:53-57.
4. Brown, C.C., Chu, K.C., 1983a. Approaches to epidemiologic analysis of prospective and retrospective studies: Example of lung cancer and exposure to arsenic, In: Risk Assessment Proc. SIMS Conf. on Environ. Epidemiol. June 28-July 2, 1982, Alta, VT. SIAM Publications.
5. Brown C.C., Chu K.C. Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. J. Natl Cancer Inst. 1983, 70:455-463.
6. Brown C.C., Chu K.C. A new method for the analysis of cohort studies Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. Environ. Health Perspect. 1983, 50:293-308.
7. Calderon R.L., Hudgens E., Le X.C., Schreinemachers D., Thomas D.J. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ. Health Perspect. 1999, 107:663-667.
8. Caldwell K.L., Jones R.L., Verdon C.P., Jarrett J.M., Caudill S.P., Osterloh J.D. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J. Expo. Sci. Environ. Epidemiol. 2009, 19:59-68.
9. California Environmental Protection Agency (CalEPA), 2008. Inorganic arsenic reference exposure levels, In: Appendix D. Individual Acute, 8-Hour, and Chronic Reference Exposure Level Summaries. (accessed 15.05.12). http://oehha.ca.gov/air/hot_spots/2008/AppendixD1_final.pdf#page=68.
10. Canada, 1999. Determination of Ni, Pb, Cd, Cr, As and Se in Mainstream Tobacco Smoke. T-109. (accessed 15.05.12). http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/tobac-tabac/legislation/reg/indust/method/_main-principal/metal-eng.pdf.
11. Canada, 2000. Official Methods for Collection of Data on Constituents. In: Tobacco reporting regulations. SOR/2000-273. (accessed 15.05.12). http://www.hc-sc.gc.ca/hl-vs/tobac-tabac/legislation/reg/indust/method/index_e.html#whole.
12. Centers for Disease Control and Prevention (CDC), 2006. National Health and Nutrition Examination Survey (NHANES). US Department of Health and Human Services. (accessed 15.05.12). http://www.cdc.gov/nchs/nhanes.htm.
13. Centers for Disease Control and Prevention (CDC), 2009. Fourth national report on human exposure to environmental chemicals. US Department of Health and Human Services. (accessed 15.05.12). http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf.
14. Centers for Disease Control and Prevention (CDC), 2005. NHANES analytic and reporting guidelines. US Department of Health and Human Services. (accessed 15.05.12). http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005.pdf.
15. Counts M.E., Morton M.J., Laffoon S.W., Cox R.H., Lipowicz P.J. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 2005, 41:185-227.
16. Cox L.A. Could removing arsenic from tobacco smoke significantly reduce smoker risks of lung cancer?. Risk Anal. 2009, 29(1):3-17.
17. Enterline P.E., Marsh G.M. Cancer among workers exposed to arsenic and other substances in a copper smelter. Am. J. Epidemiol. 1982, 116:895-911.
18. Family Smoking Prevention and Tobacco Control Act (FSPTCA), 2009. Public Law 111-31, 123 Stat. 1776. (accessed 12.06.23). http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf.
19. Federal Trade Commission (FTC), 1967. FTC to begin cigarette testing. News release. Office of Information, Washington, DC.
20. Ferreccio C., González Psych C., Milosavjlevic Stat V., Marshall Gredis G., Sancha A.M. Lung cancer and arsenic exposure in drinking water: a case-control study in northern Chile. Cad. Saude Publica 1998, 14(Suppl. 3):193-198.
21. Gebel T.W., Suchenwirth R.H., Bolten C., Dunkelberg H.H. Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure. Environ. Health Perspect. 1998, 106:33-39.
22. Gerhardsson L., Nordberg G.F. Lung cancer in smelter workers-interactions of metals as indicated by tissue levels. Scand. J. Work Environ. Health 1993, 19(Suppl. 1):90-94.
23. Higgins, I., 1982. Arsenic and respiratory cancer among a sample of Anaconda smelter workers. Report submitted to the Occupational Safety and Health Administration in the comments of the Kennecott Minerals Company on the inorganic arsenic rulemaking. (Exhibit 203-205).
24. Heck J.E., Andrew A.S., Onega T., Rigas J.R., Jackson B.P., Karagas M.R., Duell E.J. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect. 2009, 117:1718-1723.
25. International Agency for Research on Cancer (IARC), 2004a. Tobacco smoke and involuntary smoking, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 83. (accessed 15.05.12). http://monographs.iarc.fr/ENG/Monographs/vol83/index.php.
26. International Agency for Research on Cancer (IARC), 2004b. Some drinking-water disinfectants and contaminants, including arsenic, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 84. (accessed 15.05.12). http://monographs.iarc.fr/ENG/Monographs/vol84/index.php.
27. International Agency for Research on Cancer (IARC), 2007. Smokeless tobacco and some tobacco-specific N-nitrosamines, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 89. (accessed 15.05.12). http://monographs.iarc.fr/ENG/Monographs/vol89/index.php.
28. International Program on Chemical Safety (IPCS), 2001. Arsenic and arsenic compounds. 2nd edition. Environmental Health Criteria. 224. (accessed 15.05.12). http://www.inchem.org/documents/ehc/ehc/ehc224.htm.
29. Järup L., Pershagen G., Wall S. Cumulative arsenic exposure and lung cancer in smelter workers: a dose-response study. Am. J. Ind. Med. 1989, 15:31-41.
30. Kraus T., Quidenus G., Schaller K.H. Normal values for arsenic and selenium concentrations in human lung tissue. Arch. Environ. Contam. Toxicol. 2000, 38:384-389.
31. Life Sciences Research Organization (LSRO), 2008. Differentiating the health risks of categories of tobacco products. Lewis, K.D. (Ed.), Bethesda, Maryland.
32. Lugon-Moulin N., Martin F., Krauss M.R., Ramey P., Rossi L. Arsenic concentration in tobacco leaves: a study on three commercially important tobacco (Nicotiana tabacum L.) types. Water Air Soil Pollut. 2008, 192:315-319.
33. Lee-Feldstein A. Arsenic and respiratory cancer in man: Follow-up of an occupational study. Arsenic Industrial, Biomedical, and Environmental Perspectives 1982, Van Nostrand Reinhold, New York. W. Lederer, R. Fensterheim (Eds.).
34. Lumley, T., 2010. R package version 3.22-1. Survey: analysis of complex survey samples. (accessed 15.05.12). http://faculty.washington.edu/tlumley/survey/.
35. National Cancer Institute (NCI), 1999. Health effects of exposure to environmental tobacco smoke, In: Smoking and Tobacco Control Monograph no. 10. (accessed 15.05.12). http://cancercontrol.cancer.gov/tcrb/monographs/10/.
36. National Toxicology Program (NTP), 2011. Report on carcinogens, twelfth edition. (accessed 15.05.12). http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf.
37. Naufal Z.S., Marano K.M., Kathman S.J., Wilson C.L. Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999-2008. Biomarkers 2011, 16:222-235.
38. Pappas R.S., Stanfill S.B., Watson C.H., Ashley D.L. Analysis of toxic metals in commercial moist snuff and Alaskan iqmik. J. Anal. Toxicol. 2008, 32:281-291.
39. Piano, M.R., Benowitz, N.L., Fitzgerald, G.A., Corbridge, S., Heath, J., Hahn, E., Pechacek, T.F., Howard, G., American Heart Association Council on Cardiovascular Nursing, 2010. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment. A policy statement from the American Heart Association. Circulation 122, 1520-1544.
40. Pillsbury H.C., Bright C.C., O'Connor K.J., Irish F.W. Tar and nicotine in cigarette smoke. J. Assoc. Off. Anal. Chem. 1968, 52:458-462.
41. Pinto S.S., Varner M.O., Nelson K.W., Labbe A.L., White L.D. Arsenic trioxide absorption and excretion in industry. J. Occup. Med. 1976, 18:677-680.
42. Richter P.A., Bishop E.E., Wang J., Swahn M.H. Tobacco smoke exposure and levels of urinary metals in the US youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Int. J. Environ. Res. Public Health 2009, 6:1930-1946.
43. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2008. Health effects of smokeless tobacco products. (accessed 15.05.12). http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf.
44. Sexton K. Biomarkers of toxicant exposure. Toxicologic Biomarkers 2006, Taylor & Francis, New York. A.P. DeCaprio (Ed.).
45. Straif, K., Benbrahim-Tallaa, L., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Guha, N., Freeman, C., Galichet, L., Cogliano, V., WHO International Agency for Research on Cancer Monograph Working Group, 2009. A review of human carcinogens-part C: metals, arsenic, dusts, and fibers. Lancet Oncol. 10, 453-454.
46. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yen S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40:453-463.
47. Tseng W.P. Effects and dose-response relationships of skin cancer and Blackfoot disease with arsenic. Environ. Health Perspect. 1977, 19:109-119.
48. US Department of Health and Human Services (USDHHS), 2012. Guidance for industry, Reporting harmful and potentially harmful constituents in tobacco products and tobacco smoke under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act. Draft Guidance. Food and Drug Administration. Center for Tobacco Products. (accessed 16.05.12). http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM297828.pdf.
49. US Department of Health and Human Services (USDHHS), 1986. The health consequences of using smokeless tobacco. A report of the advisory committee to the Surgeon General. NIH Publication No. 86-2874. (accessed 15.05.12). http://www.surgeongeneral.gov/.
50. US Department of Health and Human Services (USDHHS), 2004. The health consequences of smoking. Atlanta, Georgia, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. (accessed 15.05.12). http://www.surgeongeneral.gov/.
51. US Environmental Protection Agency (USEPA), 1989. Risk assessment guidance for superfund. Volume I. Human health evaluation manual (Part A) Interim Final. EPA 540-1-89-002. Office of Emergency and Remedial Response, Washington, DC. (accessed 15.05.12). http://www.epa.gov/oswer/riskassessment/ragsa/.
52. US Environmental Protection Agency (USEPA), 1993. Arsenic, inorganic (CASRN 7440-38-2). Integrated Risk Information System (IRIS). (accessed 15.05.12). http://www.epa.gov/ncea/iris/index.html.
53. US Environmental Protection Agency (USEPA), 1998. Arsenic, inorganic (CASRN 7440-38-2). Integrated Risk Information System (IRIS). (accessed 15.05.12). http://www.epa.gov/ncea/iris/index.html.
54. Wasserman G.A., Liu X., Parvez F., Ahsan H., Factor-Litvak P., van Geen A., Slavkovich V., LoIacono N.J., Cheng Z., Hussain I., Momotaj H., Graziano J.H. Water arsenic exposure and children's intellectual function in Araihazar. Bangladesh. Environ. Health Perspect. 2004, 112(13):1329-1333.
55. Wester P.O., Brune D., Nordberg G. Arsenic and selenium in lung, liver, and kidney tissue from dead smelter workers. Br. J. Ind. Med. 1981, 38:179-184.
56. World Health Organization (WHO), 2011. Safety evaluation of certain contaminants in food. WHO Food Additives Series 63. FAO JECFA Monographs 8. Geneva: WHO Press. (accessed 15.05.12). http://whqlibdoc.who.int/publications/2011/9789241660631_eng.pdf.
57. Xie J., Marano K.M., Wilson C.L., Liu H., Gan H., Xie F., Naufal Z.S. A probabilistic risk assessment approach used to prioritize chemical constituents in mainstream smoke of cigarettes sold in China. Regul. Toxicol. Pharmacol. 2012, 62:355-362.